GW Resident Segment – December Edition with Dr. Shapiro
Question 1
In your JDD podcast interview, you mentioned that about 50-60% of your patients with LPP respond to naltrexone. Have you seen any similarities between these responders that could help dermatologists identify which patients would be good candidates for naltrexone as an adjunctive therapy?
Answer
"No I have not seen any similarities. The response is unpredictable."
Quest …
![superpotent](https://nextstepsinderm.com/wp-content/uploads/2017/08/JDD_Podcast.jpg)
Continue reading "GW Resident Segment – December Edition with Dr. Shapiro"
![superpotent](https://nextstepsinderm.com/wp-content/uploads/2017/08/JDD_Podcast.jpg)